News | January 8, 2021
DiCE gets its ‘library’ card ready as it speeds development of DNA database-derived molecules with more investor cash
Read More
News | January 7, 2021
CARISMA Therapeutics Completes Series B Funding to Advance Development of Novel CAR-Macrophage Immunotherapies
Read More
Press Release | December 21, 2020
Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
Read More
News | November 20, 2020
Lilly, Precision Biosciences team up on Duchenne gene therapy in $135M deal
Read More
Press Release | November 5, 2020
Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation at 62nd American Society of Hematology Annual Meeting
Read More
News | November 3, 2020
Orbus Therapeutics Publishes in Oncotarget Scientific Journal
Read More
Press Release | October 22, 2020
Orbus Therapeutics Expands Series A Financing to $71 Million to Support Ongoing STELLAR Phase 3 Study in Rare Brain Cancer
Read More
Press Release | October 19, 2020
Aptinyx Reports Positive, Statistically Significant, Top-line Data From Phase 2 Study of NYX-783 in Patients With Post-Traumatic Stress Disorder
Read More
Press Release | October 15, 2020
Precision BioSciences Announces U.S. Patent Trial and Appeal Board Upholds Allogeneic CAR T Patents
Read More
Press Release | October 14, 2020
ImCheck Announces Four ICT01 Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting
Read More
Press Release | October 9, 2020
Geeta Vemuri named Top 100 Powerful Women of 2020 by Entrepreneur
Read More
News | October 1, 2020
Skyhawk Therapeutics Named Top 11 Biotech Startup 2020 by Endpoints News
Read More
Press Release | September 17, 2020
Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors
Read More
Press Release | September 10, 2020
ImCheck Achieves Initial Positive Independent Safety Review and Initiates Next Stage of Phase I/IIa EVICTION Trial for ICT01. Company Receives FDA Approval for US IND
Read More
News | August 26, 2020
Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection
Read More
News | August 17, 2020
BMS Licenses IL-12 from Dragonfly in $475 Million Upfront Deal
Read More
News | July 29, 2020
Women in Bio: Geeta Vemuri Blazes a Trail in Venture Capital
Read More
Press Release | July 27, 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
Read More
News | July 23, 2020
Clearing the Hurdles to a Career in Venture Capital; An Interview with Geeta Vemuri
Read More
Press Release | July 16, 2020
Agent Capital Expands Management Team; Appoints Jacopo Leonardi as Partner
Read More
Press Release | July 15, 2020
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK
Read More
Press Release | July 9, 2020
ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer
Read More
Press Release | July 9, 2020
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
Read More
Press Release | July 8, 2020
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma
Read More
News | July 6, 2020
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases
Read More
Press Release | July 6, 2020
Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program
Read More
Press Release | June 26, 2020
Aptinyx to be Added to Russell 2000® Index
Read More
Press Release | June 18, 2020
Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder
Read More
News | June 3, 2020
Biotech Pliant Therapeutics pulls off $144M IPO to advance fibrosis pipeline
Read More
Press Release | May 28, 2020
Palvella Therapeutics Completes $45 Million Series C Financing
Read More
Press Release | May 26, 2020
Freenome Announces Initiation of the PREEMPT CRC Clinical Trial for the Early Detection and Prevention of Colorectal Cancer Using a Multiomics Blood Test
Read More
Press Release | May 19, 2020
HalioDx to Characterize the Immune Contexture of Patients Enrolled in ImCheck’s EVICTION Phase 1/2 Clinical Trial
Read More
Press Release | May 15, 2020
New Data from Carisma Therapeutics Uncover Potential of Expedited Pathway for Immunotherapy Development Through CAR Monocytes
Read More
Press Release | May 15, 2020
Orchard Therapeutics Presents New Interim Data from OTL-203 Proof-of-concept Study for MPS-I
Read More
News | May 12, 2020
Merck doubles down on Skyhawk’s tech to drug RNA, promising $600M per autoimmune, metabolic target
Read More
News | March 31, 2020
Latest Penn biotech spinout taking on cancer raises $1.6M from investors
Read More
Press Release | March 26, 2020
First Patient Dosed in EVICTION Trial Evaluating ImCheck’s Lead Anti-Cancer Drug, ICT01: A Novel Gamma Delta T Cell-Activating Immunotherapy
Read More
News | March 23, 2020
First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models
Read More
Press Release | March 23, 2020
Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis
Read More
Press Release | March 17, 2020
ImCheck Therapeutics Expands Leadership Team with Appointment of Hans Henrik Chrois Christensen as Chief Financial Officer and Chief Operating Officer
Read More
Press Release | March 3, 2020
Pliant Therapeutics Raises $100 Million in Series C Financing to Advance Therapies for Fibrotic Diseases
Read More
News | January 23, 2020
Business Wire Freenome Announces Encouraging Performance Data for Its Multiomics Blood Test to Detect Early-Stage Colorectal Cancer in a Prospective, Multi-Center Clinical Study
Read More
Press Release | January 8, 2020
Entrada Therapeutics Announces ENTR-501 for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
Read More
Press Release | January 6, 2020
Carisma Therapeutics Expands Leadership Team
Read More
Press Release | December 4, 2019
ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases
Read More
Press Release | November 8, 2019
Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting
Read More
Press Release | November 6, 2019
Orchard Therapeutics to Present New Registrational Data of Investigational Gene Therapies at the 61st American Society of Hematology Annual Meeting
Read More
Press Release | October 28, 2019
Aptinyx Announces Results of Phase 2 Fibromyalgia Study of NYX-2925 Have Been Selected for Late-Breaking Presentation at the American College of Rheumatology Annual Meeting
Read More
News | October 23, 2019
Novartis bets $80M on Pliant’s preclinical NASH prospect
Read More
News | July 19, 2019
Pyxis Oncology Raises $22 Million Series A
Read More
News | July 16, 2019
Genentech inks its latest discovery deal — this time turning to RNA upstart Skyhawk
Read More
News | July 8, 2019
Fattening the bankroll, Bill Haney adds cancer R&D powerhouse Merck to Skyhawk’s roster of partners out to drug RNA
Read More
News | June 10, 2019
Aptinyx Reports Top-line Data from Phase 2 in Patients with Fibromyalgia
Read More
News | June 3, 2019
Carisma Therapeutics Names Dr. Robert Petit As Chief Scientific Officer
Read More
News | May 27, 2019
Carisma Therapeutics Featured in Nature Biotechnology’s Top Academic Spin-outs 2018
Read More
Press Release | May 14, 2019
Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer
Read More
Press Release | May 6, 2019
Skyhawk Therapeutics Announces Agreement with Takeda for Neurodegenerative Diseases
Read More
News | April 9, 2019
Pliant Therapeutics Reports Positive Results Of Phase 1 Clinical Study
Read More
News | March 1, 2019
Genome editing company Precision proposes $100M IPO
Read More
News | January 16, 2019
Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
Read More
Press Release | January 4, 2019
Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets
Read More
News | January 3, 2019
Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809
Read More
News | December 18, 2018
Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita
Read More
Press Release | December 18, 2018
Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
Read More
Press Release | December 13, 2018
Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California
Read More
Press Release | December 6, 2018
Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space
Read More
News | November 27, 2018
Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy
Read More
News | November 20, 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis
Read More
News | November 5, 2018
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering
Read More
Press Release | July 16, 2018
Pliant Therapeutics Raises $62 Million in Series B Financing
Read More
Press Release | July 16, 2018
Verge Genomics Announces $32 Million Series A
Read More
News | June 27, 2018
Carisma Nabs $53 Million Series A for Cellular Cancer Therapy
Read More
Press Release | June 26, 2018
Skyhawk Therapeutics Announces $40 Million Equity Investment Round
Read More
News | June 26, 2018
Kauffman Fellows Celebrates Its Most Diverse Group of Talented Leaders With Class 23
Read More
News | June 26, 2018
Genome Editing Startup Precision BioSciences Scores $110 Million Series B
Read More
Press Release | June 26, 2018
Precision BioSciences Raises $110M
Read More
News | June 26, 2018
Skyhawk Therapeutics Gains $100 Million Through Venture Round, Collaboration
Read More
News | June 26, 2018
CAR Macrophage Tumor Tech Created by UPenn Star Scientists Gets $53M
Read More
Press Release | June 20, 2018
Aptinyx Announces Pricing of Initial Public Offering
Read More
News | April 12, 2018
UK Gene Therapy Firm Orchard Plans Stock Offer After GSK Deal
Read More
Press Release | December 20, 2017
Orchard Therapeutics Announces $110M Series B Financing
Read More
Press Release | December 18, 2017
Aptinyx Raises $70 Million in Series B Financing
Read More